June 23 (Reuters) - Invex Therapeutics Ltd (IXC) :
- GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN INJURY
- GRANTING OF ORPHAN DRUG DESIGNATION FROM EUROPEAN MEDICINES AGENCY
June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF...
Add to My Watchlist
What is My Watchlist?